Statin adherence and the risk of Parkinson's disease: A population-based cohort study
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Statin adherence and the risk of Parkinson's disease: A population-based cohort study
Authors
Keywords
Statins, Parkinson disease, Observational studies, Cholesterol, Dopaminergics, Drug therapy, Lipoproteins, Neurons
Journal
PLoS One
Volume 12, Issue 4, Pages e0175054
Publisher
Public Library of Science (PLoS)
Online
2017-04-08
DOI
10.1371/journal.pone.0175054
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- All for Statins and Statins for All; An Update
- (2015) Aris P. Agouridis et al. CURRENT PHARMACEUTICAL DESIGN
- Statins, plasma cholesterol, and risk of Parkinson's disease: A prospective study
- (2015) Xuemei Huang et al. MOVEMENT DISORDERS
- Estimating time-varying drug adherence using electronic records: extending the proportion of days covered (PDC) method
- (2015) Maarten J. Bijlsma et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Holding on to statins in Parkinson disease
- (2013) E.-K. Tan et al. NEUROLOGY
- Discontinuation of statin therapy associates with Parkinson disease: A population-based study
- (2013) Y.-C. Lee et al. NEUROLOGY
- Prospective Study of Statin Use and Risk of Parkinson Disease
- (2012) Xiang Gao ARCHIVES OF NEUROLOGY
- Time-dependent study entries and exposures in cohort studies can easily be sources of different and avoidable types of bias
- (2012) Martin Wolkewitz et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Epidemiology and etiology of Parkinson’s disease: a review of the evidence
- (2011) Karin Wirdefeldt et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- When Does Parkinson Disease Start?
- (2010) Rodolfo Savica et al. ARCHIVES OF NEUROLOGY
- Statins: Multiple neuroprotective mechanisms in neurodegenerative diseases
- (2010) Qing Wang et al. EXPERIMENTAL NEUROLOGY
- Statin use and Parkinson's disease in Denmark
- (2010) Beate Ritz et al. MOVEMENT DISORDERS
- REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century
- (2010) D. O. Claassen et al. NEUROLOGY
- Protopathic bias in observational studies on statin effectiveness
- (2009) Maarit Jaana Korhonen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Simvastatin Inhibits the Activation of p21ras and Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson's Disease
- (2009) A. Ghosh et al. JOURNAL OF NEUROSCIENCE
- Long-term persistence with statin treatment in a not-for-profit health maintenance organization: A population-based retrospective cohort study in Israel
- (2008) Gabriel Chodick et al. CLINICAL THERAPEUTICS
- Use of Statins and the Risk of Parkinson???s Disease
- (2008) Claudia Becker et al. DRUG SAFETY
- Statin use and the risk of Parkinson disease: a nested case control study
- (2008) Ali Samii et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Statins reduce neuronal α-synuclein aggregation in in vitro models of Parkinson’s disease
- (2008) Pazit Bar-On et al. JOURNAL OF NEUROCHEMISTRY
- Statin use and the risk of Parkinson disease
- (2008) A. D. Wahner et al. NEUROLOGY
- Immortal Time Bias in Pharmacoepidemiology
- (2007) S. Suissa AMERICAN JOURNAL OF EPIDEMIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now